Literature DB >> 18673437

Study of liver-targeted regulatory T cells in hepatitis B and C virus in chronically infected patients.

Hisamitsu Miyaaki1, Huijuan Zhou, Tatsuki Ichikawa, Kazuhiko Nakao, Hidetaka Shibata, Shigeyuki Takeshita, Motohisa Akiyama, Eisuke Ozawa, Satoshi Miuma, Katsumi Eguchi.   

Abstract

INTRODUCTION: Regulatory T cells (Tregs) play a critical role in chronic viral infections. The role of Tregs in chronic hepatitis B (CHB) and chronic hepatitis C (CHC) is unknown. This study examined the distribution and frequency of forkhead box p3(+) (Foxp3(+)) Tregs in the liver tissue and compared the clinicopathological characteristics of CHB and CHC patients.
METHODS: Liver needle biopsies were obtained from 26 patients who were hepatitis B surface antigen positive and 27 patients who were hepatitis C virus antibody positive.
RESULTS: The ratio of Foxp3(+) Tregs in CD3(+) T cells was similar in HBV and in HCV cases. In HBV cases, the variables that were positively associated with the ratio of Foxp3(+) Tregs in CD3(+) T cells included the serum alanine aminotransferase level (R=0.402, P=0.025) and the ratio of CD8(+) T cell plus CD56(+) NK cell against CD4(+) T cell (R=0.53, P=0.005). The ratio of Foxp3(+) Tregs in CD3(+) T cells increased more in the severe activity group than in the mild activity group (P=0.04). In HCV cases, the ratio of Foxp3(+) Tregs in CD3(+) T cells increased significantly in terms of the genotype2 (P=0.0002) and male gender (P=0.04). In addition, the ratio of Foxp3(+) Tregs in CD3(+) T cells showed a negative correlation with the ratio of CD8(+) T cell plus CD56(+) NK cell against CD4(+) T cell (R=-0.508, P=0.005) and HCV viral load (R=-0.482, P=0.001).
CONCLUSIONS: Liver-targeted regulatory T cells present similarly in CHB and CHC, but their relationship with the effector cell population, the inflammation grade or the viral load is different between CHB and CHC.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18673437     DOI: 10.1111/j.1478-3231.2008.01842.x

Source DB:  PubMed          Journal:  Liver Int        ISSN: 1478-3223            Impact factor:   5.828


  8 in total

1.  CD56+ T cells inhibit HIV-1 infection of macrophages.

Authors:  Wei Hou; Li Ye; Wen-Zhe Ho
Journal:  J Leukoc Biol       Date:  2012-05-16       Impact factor: 4.962

2.  Retention of CD4+ CD25+ FoxP3+ regulatory T cells in the liver after therapy-induced hepatitis C virus eradication in humans.

Authors:  Mark A A Claassen; Robert J de Knegt; Harry L A Janssen; André Boonstra
Journal:  J Virol       Date:  2011-03-30       Impact factor: 5.103

3.  Augmentation of hepatitis B virus-specific cellular immunity with programmed death receptor-1/programmed death receptor-L1 blockade in hepatitis B virus and HIV/hepatitis B virus coinfected patients treated with adefovir.

Authors:  Amy C Sherman; Nirupama Trehanpati; Marybeth Daucher; Richard T Davey; Henry Masur; Shiv Kumar Sarin; Shyam Kottilil; Anita Kohli
Journal:  AIDS Res Hum Retroviruses       Date:  2013-02-11       Impact factor: 2.205

4.  Expression levels of CD28, CTLA-4, PD-1 and Tim-3 as novel indicators of T-cell immune function in patients with chronic hepatitis B virus infection.

Authors:  Lin Wang; Chunnan Zhao; Qunxin Peng; Jinfang Shi; Guohao Gu
Journal:  Biomed Rep       Date:  2014-01-07

5.  The -3279C>A and -924A>G polymorphisms in the FOXP3 Gene Are Associated With Viral Load and Liver Enzyme Levels in Patients With Chronic Viral Liver Diseases.

Authors:  Leonn M S Pereira; Ednelza da Silva Graça Amoras; Simone R S da Silva Conde; Sâmia Demachki; Jaqueline C Monteiro; Rosimar N Martins-Feitosa; Andrea N M R da Silva; Ricardo Ishak; Antonio C R Vallinoto
Journal:  Front Immunol       Date:  2018-09-04       Impact factor: 7.561

6.  Detection and significance of cytotoxic cell subsets in biopsies of HCV-infected human livers.

Authors:  Iwona Mozer-Lisewska; Anna Mania; Arleta Kowala-Piaskowska; Andrzej Kluk; Husam Samara; Anna Pauli; Jan Żeromski
Journal:  Arch Immunol Ther Exp (Warsz)       Date:  2014-04       Impact factor: 4.291

Review 7.  Regulatory T-cells promote hepatitis B virus infection and hepatocellular carcinoma progression.

Authors:  Wei Li; Jun Han; Hong Wu
Journal:  Chronic Dis Transl Med       Date:  2016-11-09

8.  Expression profiles of transcription factors for special CD4+ T-cell subsets in peripheral blood mononuclear cells from patients with hepatitis B virus infection.

Authors:  Yan Xia; Xi Jin; Xueyuan Yu; Xingku Li; Bo Du; Zhen Liu; Yuguang Shi; Na Li; Shuyun Zhang
Journal:  Medicine (Baltimore)       Date:  2018-07       Impact factor: 1.889

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.